Oklahoma HB 1416: Non-opioid treatment; terms; preferred drug lists; discretion; drug treatment; United States Food and Drug Administration; coverage; non-opioid drugs; reimbursement; effective date.

Status: Second Reading referred to Health and Human Services Committee then to Appropriations Committee (as of 2025-04-01)

State: Oklahoma · Session: 2025 · Bill: HB 1416

Sponsors: Rosino, West (Josh)

View Oklahoma HB 1416 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.